Mauna Kea Technologies Announces CE Mark Grant for Urology Probes

Suwanee, Ga.-based Mauna Kea Technologies, a company focusing on the optical biopsy market and maker of Cellvizio, announced that its complete range of probes aimed at endourological applications has earned the CE Mark.

Advertisement

The range of probes — CystoFlex, CystoFlex UHD and UroFlex — can be used for flexible cystoscopy, rigid cystoscopy and ureteroscopy procedures.

More Articles on Supply Chain:  

5 Ways Materials Management Information Systems Can Improve Surgery Center Supply Chain
Mazor Robotics’ Sells Renaissance Spine System to Lawnwood Regional Medical Center
Alphatec Spine Posts $14.5M Q3 Loss After PurGen Device Discontinuation

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.